Webinar Details:

As the biopharmaceutical industry continues toward streamlined bioprocessing and intensified cell-culture biology, the selection criteria of bioreactors is becoming increasingly rigorous. Our panel of experienced, Subject Matter Experts discussed some of the key considerations when selecting bioreactor controls for modern cell culture operations.

• What factors to consider when choosing your bioreactor controls platform
• How to support a platform that scales up from lab to pilot to manufacturing
• What to consider when future proofing bioreactor control platforms
• The Catalyx bioreactor control platforms available to support different processes

Key Learnings:

• Find out about the latest innovations and best practices in biologics process scale-up, validation, and technology transfer
• Learn how to simplify bioreactor control operations
• Gain insights from experienced industry experts

Our Catalyx Expert Panel:

• Adwait Palsule, Business Unit Director and Bioreactor Controls Expert

Adwait Palsule is a Business Unit Director – Bioprocess Products at Catalyx and has been the driving force behind the development and delivery of their award-winning OpenBIO Bioreactor Product Family which is delivering significant value to Biopharmaceutical customers. Bioprocessing is an area that has been ever-present throughout Adwait’s career which spans over 20+ years.

• Michael Butler, Business Development Manager, European Market

Micheal is the European commercial manager for the Catalyx OpenBio Bioreactor Product Family. His commercial background spans over 35 years within the Life Sciences and Biologics industry. Micheal leverages his deep industry subject matter expertise and technology integration experience to help customers with biologics process scale-up, validation, and technology transfer.